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Tenascin is an important component of the glomerular extracellular
matrix in normal and pathologic conditions. Tenascin (TN), a large
oligomeric glycoprotein, is a recently described component of the
extracellular matrix (ECM). Previous reports focusing largely on the
role of TN in nephrogenesis have documented the strong expression of
TN in embryonic kidney tissue and implied an important role for TN in
nephrogenesis. However, the expression of TN in normal and patho-
logic kidneys in adults has not been systematically evaluated. In this
study immunohistochemical staining for TN was applied to 184 renal
specimens diagnosed as: normal kidney (23 cases); minimal change
disease and its variants (8); mesangial proliferative glomerulonephritis
(ON) including IgA nephropathy and mesangial proliferative lupus
nephritis (9); endocapillary proliferative ON including membranopro-
liferative ON, lupus nephritis, and post-infectious ON (25); crescentic
ON (11); membranous ON (19); focal segmental sclerosis (15); throm-
botic microangiopathy (8); amyloidosis (5); diabetic nephropathy (9);
primary tubulointerstitial nephritis (14); transplant rejection (14); and
ischemia (24). It was found that: (a) there was unequivocal global
diffuse staining limited to the mesangium in normal kidney; (b) regard-
less of the etiologies and the morphologic types of glomerular disease,
whenever there was expansion of the ECM, whether in the mesangial,
endocapillary, or extracapillary spaces, there was a concomitant and
proportional in situ increase in the TN staining; (c) globally sclerotic
glomeruli, regardless of causes, showed diffuse, strong staining, espe-
cially in the subcapsular fibrous deposition seen in ischemic sclerosis;
(d) non-sclerotic glomeruli showing early ischemic change uniformly
displayed a marked decrease or complete loss of staining; (e) in cases of
thrombotic microangiopathy, there was segmental or global staining of
the capillary wall, probably corresponding to the enlarged lamina rara
interna; (f) all nodular lesions in diabetic glomerulosclerosis showed
strong staining, but in several of them this staining was much more
pronounced in the periphery than in the center of the lesion. Our study
proves that TN is probably a component of the normal mesangial
matrix, that TN is an ubiquitous component of the expanded glomerular
ECM in pathologic conditions regardless of morphologic subtypes, and
that further studies on the cell types and mechanisms responsible for
TN synthesis may provide a new venue for the understanding of the
process of glomerular sclerosis.
Tenascin (TN), a recently described component of the extra-
cellular matrix (ECM), is a large oligomeric protein composed
of six similar units joined by disulfide bonds at their amino
terminus [1—4]. Although there are minor structural differences
among species including human, each subunit with molecular
weight ranging from 190 to 180 kd is composed of a cysteine rich
amino acid terminal domain, followed by epidermal growth
factor-like homologous repeats, fibronectin type III homolo-
gous repeats, and finally a fibrinogen /3 and y homologous
domain at the carboxyl terminal end [1—4]. Early studies sug-
gested a restricted expression of TN mainly limited to the
epithelial/mesenchymal interface of some organs such as lung
or kidney during embryogenesis. These studies also suggested
an absence of TN in normal adult tissue, and its re-expression
in various pathologic conditions including neoplasia, inflamma-
tion and repair [1—4]. Recent studies, however, have shown a
much more widespread tissue distribution of TN and suggest
that TN may constitute an important component of the ECM
under physiologic conditions [5—8].
Increased accumulation of ECM leading to glomerular scle-
rosis is a common final pathway of several glomerular diseases
regardless of their etiology [9—13]. The expanded glomerular
ECM is traditionally thought to be composed of fibronectin,
various types of collagen, laminin and heparan sulfate proteo-
glycan, all of which are known to be components of normal
glomerular ECM [10—13]. More recently, several new compo-
nents of the ECM have been described including undulin,
osteonectin, thrombospondin and TN [14—17]. Although there is
limited work on the distribution of these ECM proteins in
kidney, to the best of our knowledge there is no study focusing
on their expression and their roles in glomerular diseases
[14—17]. On the other hand, a detailed knowledge on the
structural components of glomerular sclerosis is essential for
further studies on other fundamental aspects of this pathoge-
netically important process.
Therefore, we undertook a systematic evaluation of the
glomerular distribution of TN in normal kidney and in a large
variety of renal diseases. The functional and morphologic
implications, as well as possible mechanisms controlling the TN
expression in glotnerular diseases are also discussed.
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Materials
One hundred and eighty-four cases (143 renal biopsies and 41
nephrectomy specimens) were selected for this study. The
201
202 Truong et al: Tenascin in normal and pathologic glomeruli
Normal kidney
Adjacent to renal cell carcinoma
From autopsy
Minimal change disease and its variants
Mesangial proliferative GN
Mesangial lupus nephritis (Class II)
Mesangial IgA nephropathy
Focal segmental sclerosis
Idiopathic
"Secondary"
Endocapillary proliferative ON
Membranoproliferative ON
Segmental proliferative lupus (Class III)
Diffuse proliferative lupus (Class IV)
Proliferative IgA nephropathy
Crescentic ON
Goodpasture syndrome
Wegener granulomatosis
Membranoproliferative GN
IgA nephropathy
Idiopathic
Membranous ON
Lupus (Class V)
Non-lupus
Diabetic glomerulosclerosis
Amyloidosis
Primary chronic tubulointerstitial nephritis
Idiopathic
Chronic pyelonephritis
Acute tubular necrosis
Cyclosporine nephrotoxicity
Lithium toxicity
Cast nephropathy
Rejection
Acute
Chronic
Thrombotic microangiopathy
HUS/TTP
Chronic transplant glomerulopathy
Associated with lupus
Ischemic damage
Renal arterial stenosis
Arteriolonephrosclerosis
Kidney tissue adjacent to renal tumor
"Ischemic" damage in cases of chronic
tubulointerstitial nephritis
Total
10
5
8
4
3
10
2
3
1
1
4
6
13
3
7
10
4
diagnoses of these cases, summarized in Table 1, were classi-
fied into 13 major categories: (1) "normal" kidney tissue
obtained from nephrectomy specimens for renal cell carcinoma,
or from patients who died of nonrenal causes (23 cases); (2)
minimal change disease and its variants characterized by a mild
degree of focal, segmental mesangial sclerosis and/or mesangial
cell hypercellularity with or without C3 and/or 1gM staining in
mesangial areas (8 cases); (3) mesangial proliferative glomeru-
lonephritis (GN) characterized by moderate to marked mesan-
gial sclerosis and hypercellularity (9 cases); (4) focal segmental
sclerosis (FSS) which included the idiopathic category (10
cases) and the "secondary" category in which the sclerotic
change of the glomeruli is a nonspecific component of well-
defined entities such as nephropathy associated with heroin
addiction, human immunodeficiency virus-associated nephrop-
athy, or arterionephrosclerosis (5 cases); (5) endocapillary
proliferative GN characterized by global diffuse or focal seg-
Antibodies
The antibody used for this study is a mouse monoclonal
antibody directed against purified human TN obtained from
cultured U251 glioma cells (Dako Corporation, Carpinteria,
California, USA). Although the manufacturer claims that the
antibody does not cross react with fibronectin, fibrinogen, and
epidermal growth factor, we proceeded to confirm the specific-
ity of this antibody by immunoblotting and absorption study.
For the immunoblotting study, fibronectin (Sigma Chemical
Company, St. Louis, Missouri, USA) and laminin (Sigma
Chemical Company) proteins extracted from normal human
kidney and proteins extracted from normal human aortic wall
were electrophoresed on polyacrylamide gel. Protein extraction
was done by direct dissolving of the snap-frozen fresh tissue
into SDS-sample buffer (0.0625 M Tris-HCI pH 6.8, 2%, SDS,
5%, 2-mercaptoethanol, 10% glycerol and 0.002% Bromophenol
Blue). The blot was subsequently reacted with the anti-TN
Table 1. Cases used for the staining of tenascin 1 2 3 4 5 6
20
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Fig. 1. Immunoblotting study. Lane 1 contains proteins extracted from
normal human aortic wall, this lane serves as a control in which the
primary antibody is replaced by buffer; the blot also contains molecular
weight markers (lane 2), proteins extracted from normal human kidney
(lane 3), proteins extracted from normal human aortic wall (lane 4),
19 fibronectin (lane 5) and laminin (lane 6). Distinct bands of tenascin
isoforms are seen in lane 3 and 4 only (anows).
9
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14
mental endocapillary cell proliferation (25 cases); (6) crescentic
GN (11 cases); (7) membranous ON (19 cases); (8) thrombotic
microangiopathy (8 cases); (9) diabetic nephropathy (9 cases);
(10) amyloidosis (5 cases); (11) primary tubulointerstitial ne-
phritis (14 cases); (12) transplant rejection (14 cases); and (13)
14 cases characterized predominantly by ischemic damage such as
arterionephrosclerosis, renal arterial stenosis, or kidney tissue
adjacent to renal cell carcinoma (24 cases).
8
Tissue preparations
Staining was performed on fresh frozen tissue only (13 cases),
24 fixed tissue only (42 cases), and both fixed and frozen tissue
(129 cases). For frozen tissue, selected tissue blocks were
embedded on OCT mounting medium, snap frozen at 70°C, and
4 t sections cut. When fixation was used, tissue was fixed in
either 10% buffered formalin, Zamboni fluid, or B5 fixative
184 (containing 1.0 M formaldehyde, 0.3 M glyoxal and 60% meth-
— anol) for up to 10 hours. The specimens were embedded in
paraffin and 4 sections were cut.
2
4
3
3
9
5
4
3
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Fig. 2. Six normal glomeruli from a frozen
tissue section display strong, global staining
for tenascin limited to the mesangial matrix.
The glomerular basement membrane does not
show any staining (Immunoperoxidase with
light methyl green counterstain, x520).
Fig. 4. Mesangial proliferative IgA nephropathy. A glomerulus dis-
plays strong global staining of the enlarged mesangial matrix. (Immu-
noperoxidase with light methyl green counterstain x 1040).
antibody. For the absorption study, the anti-TN antibody and a
polyclonal antibody against fibronectin (Dako Corporation) at
optimal dilutions for immunohistochemistry were mixed with
human plasma fibronectin (25 g'ml and 50 p.g/ml) for two hours
at room temperature. These antibodies, without further treat-
ment, were then used for immunostaining of the sections known
to contain a large amount of TN. Pure TN was not available to
us.
Staining techniques and methods of observation
Fig. 3. Focal segmental sclerosis. (A) HI V-related nephropathy: Fresh
frozen kidney tissue shows collapse of glomerular capillaries; tenascin
staining is seen in all mesangial areas and an area of segmental sclerosis
(arrow). (B) Idiopathic focal segmental sclerosis: Due to fixation, only
rare mesangial areas (solid arrows) in this glomerulus show staining for
tenascin. Nevertheless, the areas of segmental sclerosis (open arrows)
show strong staining. (Imrnunoperoxidase with light methyl green
counterstain, x 1040 for both figures).
The standard avidin-biotin-peroxidase complex technique
was used [18]. Briefly, the staining procedure for fixed tissue
included: (a) rehydration; (b) digestion with type XIV protease
(Sigma Chemical Company) (0.02% protease in 0.05 M Tris
buffer, pH 7.6, 0.025% CaC12, 7 mm at 370); (c) treatment with
10% normal horse serum in PBS for 30 minutes to prevent
non-specific staining; (c) incubation with primary antibody
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Fig. 5. Endocapillary proliferative glomerulonephritis. (A) Membran-
oproliferative glomeruloncphritis. A glomerulus displays global staining
of the expanded extracellular matrix. Staining of the matrix in areas of
mesangial interposition (arrowheads) is seen. (Immunoperoxidase with
light methyl green counterstain, x 1040). (B) Wegener's granulomatosis.
The extracellular matrix in the endocapillary proliferative lesion (ar-
rowheads) involving two adjacent glomeruli is strongly stained for
tenascin, A small crescent (arrow) also shows staining, as do the
mesangial areas of the uninvolved capillary tufts. (Immunoperoxidase
with light methyl green counterstain, X520).
diluted to 1/100 in PBS for one hour; (d) incubation with horse
polyclonal secondary antibody directed against mouse immu-
noglobulins (Vector Laboratories, Burlingame, California,
USA) at 1/100 dilution for one hour at room temperature; (e)
avidin-biotin-peroxidase complex (Vector Laboratories), at
1/100 dilution for one hour at room temperature); (1) color
development with diaminobenzidine (Sigma Chemical Compa-
ny), 50 mg% for six minutes at room temperature; (g) counter-
stain with methyl green 4% for 15 minutes at room temperature.
For frozen tissue, a similar procedure was followed, except that
digestion with protease was omitted. Tissue sections from a
decubitus ulcer were used as a positive control. The negative
controls included replacement of the primary antibody, the
secondary antibody, and the avidin-biotin peroxidase complex,
respectively, with PBS. The glomeruli did not show any stain-
ing in these control slides, indicating not only the specificity of
the primary antibody, but also the absence of endogenous
avidin binding activity and the endogenous peroxidase activity
in the glomeruli.
Fig. 6. Crescentic glomerulonephritis. A Lupus crescentic glomerulo-
nephritis. This glomerulus is surrounded by periglomerular fibrosis (F),
winch is stained strongly positive. Inner to this layer is a predominantly
cellular crescent (C), in which a few strands of extracellular matrix
(arrows) showing positive staining for tenascin are seen. The underlying
glomerular capillaries display global endocapillary cell proliferation
with strong staining of the intervening extracellular matrix. (Immuno-
peroxidase with slight methyl green counterstain, x 1040). (B) Idio-
pathic crescentic glomerulonephritis: This fibrocellular crescent (right)
shows strong and diffuse staining of the extracellular matrix. Compare
with the more localized staining of a predominantly cellular crescent in
A. (Immunoperoxidase with slight methyl green counterstain, x 1040).
All the materials were independently observed by two of the
authors (LT and JP); any existing differences were resolved by
simultaneous observation through a two-headed microscope.
Results
Immunoblotting and absorption studies
The immunoblotting studies showed distinct bands of TN
isoforms for the proteins extracted from normal human kidney
tissue and from normal human aortic wall, respectively,
whereas the fibronectin and laminin lanes did not show any
reaction (Fig. 1).
In the absorption study, the mesangial matrix was stained
strongly with both the anti-TN antibody and the antifibronectin
antibody. This staining pattern for TN was unchanged after the
anti-TN antibody was absorbed with fibronectin, whereas the
staining with antifibronectin antibody was completely abolished
when this antibody was similarly absorbed. These results
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Fig. 7. Membranous glomerulonephritis. A glomerulus with segmental
peripheral staining of the capillaries (arrows). This case of membranous
glomerulonephritis is in stage III and characterized ultrastructurally by
marked disorganization and thickening of the glomerular basement
membrane, and reabsorption of the intramembranous electron dense
deposits. We suggest that the tenascin staining is related to these
changes. Probably due to fixation, staining is noted only in some
mesangial areas (arrowhead). (Immunoperoxidase with light methyl
green counterstain, x 1040).
Fig. 8. Thrombotic microangiopathy. This glonierulus shows staining
of mesangium and capillaries; the latter areas may correspond to a
widened lamina rara interna (arrowheads). (Immunoperoxidase with
light methyl green counterstain, x 1040).
confirmed that the anti-TN antibody does not cross react with
fibronectin.
Control studies
All the positive and negative controls for the staining of tissue
sections using the anti-TN antibody yielded appropriate results.
A parallel comparative study done in 129 cases showed that the
antibody gave satisfactory staining for both fresh frozen and
fixed tissue. In several cases, the fixed and frozen tissue were
complementary in evaluating the intensity and the precise
localization of TN staining because, although staining was
stronger in frozen tissue, precise identification of the stained
structures, in most instances, was possible only in fixed tissue.
Fig. 9. Amyloidosis. This globally sclerotic glomerulus shows expan-
sion of extracellular matrix, which is stained for tenascin, whereas the
adjacent amyloid deposition (asterisks) shows a negative reaction.
(Immunoperoxidase with light methyl green counterstain, x 1040).
Normal glomeruli
Only mesangial matrix was stained. Focal, segmental and
weak staining of mesangial matrix was noted on most fixed
tissue specimens; however, strong, global, diffuse mesangial
staining was present in a few fixed tissue specimens and in all
frozen tissue specimens from normal kidney (Fig. 2).
Glomeruli with pathological changes
Abnormal glomeruli, regardless of the pathologic diagnosis,
retained the mesangial staining pattern seen in normal tissue.
Superimposed on that pattern, additional staining for TN was
consistently observed in the expanded ECM, whether this
expansion occurred in the mesangial areas, in the endocapillary
proliferative lesion, in the areas of mesangiaJ interposition, in
the crescents, or in the periglomerular areas. It was also noted
that the expanded ECM showed strong staining for TN in fixed
tissues, even when fixation caused a significant loss of TN
staining of the mesangial matrix in the adjacent normal glomer-
uli (Fig. 3 A and B).
There was global, diffuse, mesangial staining for the cases of
minimal change disease and its variants. This is one more
example of the minimal abnormalities seen in this condition.
The areas showing segmental glomerulosclerosis in both
idiopathic and secondary FSS displayed strong and diffuse
staining (Fig. 3 A and B).
In the cases of mesangiopathic GN, the enlarged mesangial
matrix was diffusely stained (Fig. 4).
In cases of proliferative GN, there was either proliferation of
endocapillary cells separated by expanded ECM, and/or mesan-
gial interposition characterized by extension of mesangial ECM
and mesangial cells to subendothelial space. The expanded
ECM in either situation was stained strongly positive for TN.
More advanced lesions characterized by a reduction in cellu-
larity and increased ECM displayed increased TN staining that
paralleled the degree of ECM accumulation (Fig. 5 A and B).
In all cases of crescentic GN, the crescents displayed TN
staining of the ECM, the extent and the intensity of which
reflected the stages of the crescents, being least in the cellular
and most in the fibrous crescents, respectively (Fig. 6 A and B).
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Fig. 10. Diabetic glomerulosclerosis. (A) A nodular lesion with tenascin staining of extracellular matrix (arrowheads), the staining is more
pronounced at the peripheral and more cellular area of the lesion. Other mesangial areas are enlarged to a lesser degree and shows weaker tenasin
staining limited to the periphery. An area of capsular synechea (lower left) shows strong staining. The glomerular basement membrane is not
stained. (B) Diffuse staining of the expanded mesangial matrix. The glomerular basement membrane is not stained. (C) Although the expanded
extracellular matrix shows strong tenascin staining, the insudative lesion (asterisks) shows a negative reaction. (0) This globally sclerotic
glomerulus shows diffuse staining. (Immunoperoxidase with light methyl green counterstain, x 1040 for all figures).
In 4 of 19 cases of membranous GN, rare glomerular capil-
laries showed peripheral staining (Fig. 7). In all four cases, the
membranous GN was in stage III and was characterized by
significant thickening of the glomerular basement membrane
and a focally clear, or fluffy or electron variegated appearance
of several intramembranous deposits. Glomerular capillary wall
staining was not noted in remaining cases of membranous ON,
only one of which was in stage Ill.
In each case of thrombotic microangiopathy, there was a
variable degree of staining of some glomerular capillaries;
although the exact localization of the staining was not always
possible, careful examination under an oil-immersion lens sug-
gested that the staining corresponded to a widened lamina rara
interna (Fig. 8).
In cases of amyloidosis, the expanded ECM adjacent to the
amyloid was stained, but not the amyloid itself (Fig. 9).
In every case of either diffuse or nodular diabetic glomerulo-
sclerosis, the enlarged mesangial ECM was stained strongly
(Fig. 10 A and B); however, in several mesangial nodules, the
peripheral portion of the nodules was stained much stronger
than the center (Fig. 10 A and B). No staining was observed in
the thickened glomerular basement membrane or areas of
hyalinosis (Fig. bC). Globally sclerotic glomeruli due to dia-
betic glomeruloscierosis showed strong and diffuse staining for
TN (Fig. 1OD).
In the cases of graft rejection included in this study, a broad
spectrum of glomerular changes, similar to those noted in other
reports, was observed ranging from normal to marked glomer-
ular hypercellularity and expanded ECM. The TN staining
faithfully paralleled the distribution and severity of ECM ex-
pansion. Moreover, two other interesting staining patterns were
seen in some kidneys. First, in several cases of chronic trans-
plant glomerulopathy, there was focal peripheral staining of the
glomerular capillaries, which probably corresponded to the
widened lamina rara interna (Fig. 1 1A) similar to that seen in
thrombotic microangiopathy (Fig. 8). Second, several glomer-
ular capillaries with acute thrombosis, a feature usually seen in
acute vascular rejection, displayed strong staining of their wall
(Fig. biB).
In cases of primary tubulointerstitial nephritis, although the
unaffected glomeruli showed a staining pattern similar to that of
normal control, glomeruli with "ischemic" damage showed a
peculiar change, described below.
In cases of arterionephrosclerosis or renal arterial stenosis, a
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Fig. 11. (A) Chronic transplant glomerulopathy. This glomerulus
shows peripheral, probably subendothelial staining; the cellular cres-
cent, however, is not stained. (B) Acute, severe vascular rejection. The
glomerulus displays global mesangial staining; in addition, one glomer-
ular capillary with thrombosis (asterisk) displays strong staining of the
wall. (Immunoperoxidase with light methyl green counterstain, X 1040
for both figures).
significant number of glomeruli displayed characteristic
changes including smaller glomerular size, irregular thickening,
wrinkling and partial collapse of glomerular basement mem-
brane and focal subcapsular fibrosis. This combination of
findings is thought to reflect "early ischemic" damage to the
glomeruli. Glomeruli with ischemic changes displayed a vari-
able staining pattern depending on the stages of the ischemic
damage. In early stages, the glomerular tufts showed marked
decrease or complete loss of staining, whereas the subcapsular
fibrosis stained strongly (Fig. 12 A and B). In later stages, when
the ischemic glomeruli develop global sclerosis, both the gb-
merular tufts and the subcapsular fibrosis displayed staining,
but the staining of the latter was always stronger than that of the
former (Fig. 12B). The peculiar loss of TN staining in glomeruli
with early ischemic changes is not an artifact because: (a) this
pattern was observed in both fresh frozen and fixed tissue; (b)
in three cases of segmental renal arterial sclerosis, this loss was
present in some gbomeruli whereas adjacent normal or globally
sclerotic glomeruli showed strong staining; and (c) collagen
type IV and fibronectin were readily demonstrated immunohis-
tochemically in glomeruli with early ischemic changes.
Finally, all globally sclerotic glomeruli, regardless of etiol-
ogy, displayed strong, diffuse staining (Figs. IOD and 12B).
Discussion
To the best of our knowledge, the distribution of TN in
abnormal kidney tissue was addressed in only two previous
studies [7, 19—23]. One is a general review on TN distribution in
human tissue in which an increased staining for TN in "gbom-
erulopathies" and "interstitial nephritides" was briefly men-
tioned without further details on the pathologic process or the
number of evaluated cases [7]. In the other study, 26 renal
transplant biopsies showing acute or chronic rejection were
studied [211. On the other hand, it is obvious that a detailed
knowledge on the composition of glomerular sclerosis, a com-
mon final pathway for all glomerular lesions, is essential for,
and indeed, should stimulate further studies illustrating other
fundamental aspects of this pathogenetically important process.
Our study demonstrates that TN is ubiquitously present in
normal and pathologic gbomeruli of the mature human kidney. It
suggests that TN is a component of mesangial matrix in the
normal mature human kidney. In keeping with these immuno-
histochemical observations is our finding that normal rat me-
sangial cells in culture synthesize and secrete TN into the ECM
and the supernatant (manuscript submitted for publication).
Our study also shows that regardless of the etiology and the
type of gbomerular disease, whenever there is expansion of the
ECM, whether in the mesangial, endocapillary or extracapillary
spaces, or involving the entire glomerulus (global sclerosis),
there is a concomitant and proportional in situ increase in the
expression of TN.
Our study also revealed some unexpected but interesting
staining patterns which may have pathogenetic implications.
First, there is a marked decrease or complete loss of TN
staining of glomeruli with early ischemic changes. This staining
pattern, observed in both frozen and fixed tissue in every case
with ischemic damage, does not seem to represent an artifact.
Its etiologies are poorly understood, but may be related to a
true cessation of TN synthesis or neosynthesis of an isoform of
TN not recognizable by the antibody used in this study.
Second, there was focal staining of glomerular capillary wall in
most cases of stage III membranous GN. Although an exact
localization of TN staining is not possible without immunoelec-
tron microscopy, this staining may be related to the thickened,
reorganized glomerular basement membrane and/or the areas
where intramembranous electron dense deposits develop a
fluffy or electron variegated appearance; all these features are
characteristically seen in stage III membranous GN, but not in
earlier stages. Third, unequivocal focal or diffuse staining of the
glomerular capillary walls, probably localized to the widened
lamina interna, was observed in cases of thrombotic microan-
giopathy. Previous studies have shown that the widened lamina
rara interna, a feature shared by thrombotic microangiopathy of
different etiologies, is composed at least partly of fibrinogen-
fibrin products and laminin [24, 25]. Our study suggests that TN
may be another component of this lesion. Fourth, in most
nodular lesions of diabetic gbomeruloscierosis, the peripheral
portion of the lesion, which presumably represents more recent
deposition of ECM, was stained much more strongly for TN
than that in the center. Pertinent to this interesting staining
pattern is the observation that in some other organs including
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Fig. 12. (A) Early ischemic damage. A glomerulus displays a
complete loss of staining of the glomerular tuft; however, there is
strong staining of the subcapsular fibrosis, which typically
develops first at vascular pole. (Immunoperoxidase with light
methyl green counterstain, x 1040).
FIg. 12. (B) Segmental renal arterial stenosis.
The interface between the ischemic and
nonisehemic areas shows three populations of
glomeruli. The intact glomerulus (left) show
global mesangial staining; the glomeruli with
early ischemia (right) show a loss of staining
of glomerular tufts but staining of the early
subcapsular fibrosis (arrowheads) is noted; the
three globally sclerotic glomeruli (center)
display global staining of the glomerular tufts.
In one of these glomeruli, strong staining of
the well developed subcapsular fibrosis
(asterisk) is evident. (Immunoperoxidase with
light methyl green counterstain, x520).
skin, TN is strongly expressed in young scar tissue, and
gradually disappears when the scar becomes mature [26]. All
the above observations would imply that although TN expres-
sion is ubiquitous in pathologic processes involving glomeruli,
this expression is complex and probably involves various
isoforms of TN with different functional and morphological
implications for different glomerular lesions and for a single
type of lesion at different stages of evolution.
What cell types are responsible for TN synthesis? In normal
conditions, the best candidate is the mesangial cell. This
possibility is supported by the exclusive mesangial staining of
normal glomeruli and by our observation that normal rat
mesangial cells in culture synthesize and secrete TN into ECM
(manuscript submitted for publication). In pathologic condi-
tions, all three types of resident glomerular cells, that is,
mesangial, endothelial and epithelial may be responsible for TN
synthesis. Supporting evidence includes: (a) vascular smooth
muscle cells, at least from aorta, have been shown to synthesize
TN [27, 28J; (b) early crescents which are known to be
composed mostly of epithelial cells show unequivocal TN
staining in our study; (c) the glomerular basement membrane,
which is closely related to both endothelial and visceral epithe-
lial cells, shows TN staining at least in cases of membranous
GN and thrombotic microangiopathy; and (d) TN expression by
visceral epithelial cells was recently noted in rats with 5/6
nephrectomy [16].
The significance of TN accumulation in pathologic glomeruli
is not entirely known. It has been noted that there is differential
participation of ECM proteins in the process of glomeruloscle-
rosis. For example, fibronectin was thought to be a more
important component than either collagen type IV or laminin in
a murine model of graft-versus-host glomerulosclerosis, and
probably in glomerulosclerosis in humans [11—131. How impor-
tant the role of TN in relation to those of other ECM proteins in
the process of glomeruloscierosis has not been determined;
nevertheless, the strong and ubiquitous staining of TN in both
normal and pathologic glomeruli suggests that TN is a common
and crucial participant in such a process. Indeed, TN is
probably not a mere structural component, passively participat-
ing in the process of glomerular scarring, but may influence the
,_;_ . •
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phenotype and function of the cells it surrounds [29]. In this
respect, the amino acid sequence Arg-Gly-Asp, responsible for
binding ECM proteins to integrins, has been identified in one of
the fibronectin type III repeats in the TN subunits [1, 3] and
some integrin families have been identified in human glomeruli
and human mesangial cells [9, 30, 31].
The mechanisms controlling the expression of TN in glomer-
uli have not been elucidated. Epithelial cells in culture, as well
as in embryogenesis of several organs including breast, lung,
gut, and kidney, can induce TN synthesis by mesenchymal cell
[22, 32—34], an effect which may be partially mediated through
the transforming growth factor (TGF) secreted by epithelial
cells [22, 32, 33, 34]. It has been documented that mesangial
cells are a source of TGF [35], and that increased expression of
TGF occurs in some types of glomerular diseases [36]. Coagu-
lation may also play a role in TN synthesis. Pertinent to this
hypothesis is the observation from our study that in cases of
severe vascular rejection of the kidney, the glomerular capillar-
ies with thrombosis display strong staining of their walls.
Moreover, we have recently observed that thrombin, which has
a known mitogenic effect on endothelial and mesangial cells [37,
38], enhances the synthesis of TN by both smooth muscle cells
and mesangial cells in culture (manuscript submitted for publi-
cation). The available preliminary data suggest that TN synthe-
sis in glomeruli may be modulated by a complex interplay of
several factors including growth factors, hemodynamics and the
coagulation process.
In summary, this study strongly suggests that in human TN is
not only a component of normal mesangial matrix, but is also
ubiquitously present in the expanded ECM of abnormal glomer-
uli regardless of the site of the expansion or the underlying
pathologic processes. Further studies on the cell types and the
mechanisms responsible for TN synthesis may provide a new
venue for the understanding of glomerular sclerosis, the com-
mon final pathway of all glomerular diseases.
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Note added in proof
Assad et al reported increased TN expression in a study of normal
kidney (5 cases), minimal change disease (5), membranous glomerulo-
nephritis (10), segmental necrotizing glomerulonephritis (5) and diffuse
lupus glomerulonephritis (5). A55AD L, SCHWARTZ MM, VIRTANEN I,
GOULD YE: Immunolocalization of tenascin and cellular fibronectins in
diverse glomerulopathies. Virchow Arch 63:307—3 16, 1993
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